Literature DB >> 7713556

Macrophage activation and innate resistance to infection in SCID mice.

G J Bancroft1, J P Kelly.   

Abstract

Resistance to infection against a variety of pathogens requires the co-ordinated interaction of both the innate and acquired immune responses. Mice bearing the SCID mutation are devoid of T and B cells but retain elements of the innate immune system including natural killer (NK) cells, macrophages, granulocytes and complement proteins. Using the SCID model we have identified a T cell independent mechanism of macrophage activation mediated by the secretion of IFN-gamma from NK cells. This process occurs in response to a variety of parasites and bacteria including Listeria monocytogenes, and is strictly regulated both in vitro and in vivo by cytokines such as IL-2 and IL-10. Here we discuss the mechanisms of NK cell activation and regulation and describe a new model of opportunistic infection in SCID mice with the AIDS related pathogen Cryptosporidium parvum.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7713556     DOI: 10.1016/S0171-2985(11)80448-1

Source DB:  PubMed          Journal:  Immunobiology        ISSN: 0171-2985            Impact factor:   3.144


  21 in total

1.  NCOA1 Directly Targets M-CSF1 Expression to Promote Breast Cancer Metastasis.

Authors:  Li Qin; Ye-Lin Wu; Michael J Toneff; Dabing Li; Lan Liao; Xiuhua Gao; Fiona T Bane; Jean C-Y Tien; Yixiang Xu; Zhen Feng; Zhihui Yang; Yan Xu; Sarah M Theissen; Yi Li; Leonie Young; Jianming Xu
Journal:  Cancer Res       Date:  2014-04-25       Impact factor: 12.701

2.  Disruption of the cellular inflammatory response to Listeria monocytogenes infection in mice with disruptions in targeted genes.

Authors:  J DiTirro; E R Rhoades; A D Roberts; J M Burke; A Mukasa; A M Cooper; A A Frank; W K Born; I M Orme
Journal:  Infect Immun       Date:  1998-05       Impact factor: 3.441

3.  Protective responses against skin-dwelling microfilariae of Onchocerca lienalis in severe combined immunodeficient mice.

Authors:  S G Folkard; M J Taylor; G A Butcher; A E Bianco
Journal:  Infect Immun       Date:  1997-07       Impact factor: 3.441

4.  Neural route of cerebral Listeria monocytogenes murine infection: role of immune response mechanisms in controlling bacterial neuroinvasion.

Authors:  Y Jin; L Dons; K Kristensson; M E Rottenberg
Journal:  Infect Immun       Date:  2001-02       Impact factor: 3.441

5.  Replication of murine cytomegalovirus in differentiated macrophages as a determinant of viral pathogenesis.

Authors:  L K Hanson; J S Slater; Z Karabekian; H W Virgin; C A Biron; M C Ruzek; N van Rooijen; R P Ciavarra; R M Stenberg; A E Campbell
Journal:  J Virol       Date:  1999-07       Impact factor: 5.103

6.  Calcineurin and vacuolar-type H+-ATPase modulate macrophage effector functions.

Authors:  I M Conboy; D Manoli; V Mhaiskar; P P Jones
Journal:  Proc Natl Acad Sci U S A       Date:  1999-05-25       Impact factor: 11.205

Review 7.  Genetics-squared: combining host and pathogen genetics in the analysis of innate immunity and bacterial virulence.

Authors:  Jenny Persson; Russell E Vance
Journal:  Immunogenetics       Date:  2007-09-14       Impact factor: 2.846

8.  Re-evaluating natural resistance to herpes simplex virus type 1.

Authors:  William P Halford; John W Balliet; Bryan M Gebhardt
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

Review 9.  Orthotopic mouse models for the preclinical and translational study of targeted therapies against metastatic human thyroid carcinoma with BRAF(V600E) or wild-type BRAF.

Authors:  Z A Antonello; C Nucera
Journal:  Oncogene       Date:  2013-12-23       Impact factor: 9.867

10.  Glucocorticoid-induced tumor necrosis factor receptor negatively regulates activation of human primary natural killer (NK) cells by blocking proliferative signals and increasing NK cell apoptosis.

Authors:  Baoying Liu; Zhuqing Li; Sankaranarayana P Mahesh; Seth Pantanelli; Frank S Hwang; Willie O Siu; Robert B Nussenblatt
Journal:  J Biol Chem       Date:  2008-01-29       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.